Revision EpidA: Regulatory Impact Assessment - Part 1

  • Funded by State Secretariat for Education, Research, and Innovation SERI (Staatssekretariat für Bildung, Forschung und Innovation)
  • Total publications:0 publications

Grant number: 142004701

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2022
    2023
  • Known Financial Commitments (USD)

    $125,427.97
  • Funder

    State Secretariat for Education, Research, and Innovation SERI (Staatssekretariat für Bildung, Forschung und Innovation)
  • Principal Investigator

    Wäfler Karin
  • Research Location

    N/A
  • Lead Research Institution

    N/A
  • Research Priority Alignment

    N/A
  • Research Category

    Policies for public health, disease control & community resilience

  • Research Subcategory

    Policy research and interventions

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

On June 19, 2020, the Federal Council commissioned the FDHA to start a partial revision of the Epidemics Act (EpG). The law is intended to enable the federal government and the cantons to work closely together to protect the health of the population from future threats from communicable diseases and to take the necessary precautionary measures in good time. The revised law addresses the findings from the implementation of the EpG before the Covid-19 pandemic, the findings from the Covid-19 response, but also new developments, e.g. with regard to digitalization. The regulatory impact assessment (RFA) is an instrument for examining and presenting the economic effects of federal proposals. This RFA examines the impact of the revised EpG.